State of the art: Atherosclerosis in a limited edition
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Link
http://www.nature.com/articles/nm0898-899.pdf
Reference16 articles.
1. Hennekens, C.H. Increasing burden of cardiovascular disease: Current knowledge and future directions for research on risk factors. Circulation 97, 1095–1102 (1998).
2. Gould, L.A., Rossouw, J.E., Santanello, N.C., Heyse, J.F. & Furberg, C.D. Cholesterol reduction yields clinical benefit: Impact of statin trials. Circulation 97, 946–952 (1998).
3. Powell-Braxton, L.M. et al. A mouse model of human familial hypercholesterolemia: Markedly elevated low density lipoprotein cholesterol levels and severe atherosclerosis on a low-fat, chow diet. Nature Med. 4, 934–938 (1998).
4. Sanan, D.A. et al. Low density lipoprotein receptor-negative mice expressing human apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: No accentuation by apolipoprotein (a). Proc. Natl. Acad. Sci. USA 95, 4544–4549 (1998).
5. Paigen, B., Morrow, A., Holmes, P.A., Mitchell, D. & William, R.A. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis 68, 231–240 (1987).
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. SVEP1 is a human coronary artery disease locus that promotes atherosclerosis;Science Translational Medicine;2021-03-24
2. SVEP1, a novel human coronary artery disease locus, promotes atherosclerosis;2020-06-16
3. Chlamydia pneumoniaeInfection Exacerbates Atherosclerosis in ApoB100only/LDLR−/−Mouse Strain;BioMed Research International;2018
4. Nonclinical Pharmacology/Toxicology Study of AAV8.TBG.mLDLR and AAV8.TBG.hLDLR in a Mouse Model of Homozygous Familial Hypercholesterolemia;Human Gene Therapy Clinical Development;2017-03
5. Changes in Plasma Lipid Levels and Antioxidant Activities in Rats after Supplementation of Obtusifolin;Planta Medica;2016-03-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3